| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,514 |
5,313 |
$227K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,685 |
2,386 |
$142K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
939 |
915 |
$82K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
770 |
756 |
$66K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
621 |
599 |
$52K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
800 |
734 |
$27K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
267 |
261 |
$22K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
665 |
570 |
$22K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,437 |
662 |
$16K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
460 |
438 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,368 |
1,191 |
$10K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,848 |
2,618 |
$10K |
| 99401 |
|
1,326 |
1,111 |
$5K |
| 0071A |
|
92 |
92 |
$3K |
| 0002A |
|
68 |
55 |
$3K |
| 0001A |
|
63 |
61 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,308 |
966 |
$2K |
| 90686 |
|
470 |
456 |
$2K |
| 90461 |
|
1,011 |
921 |
$2K |
| 0072A |
|
75 |
74 |
$2K |
| 92552 |
|
317 |
297 |
$2K |
| 90651 |
|
30 |
30 |
$1K |
| 90700 |
|
301 |
293 |
$1K |
| 99058 |
|
1,772 |
1,598 |
$1K |
| 80061 |
Lipid panel |
192 |
178 |
$949.88 |
| 90619 |
|
33 |
33 |
$903.38 |
| 90713 |
|
144 |
144 |
$865.64 |
| 99173 |
|
862 |
826 |
$856.71 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
46 |
43 |
$755.00 |
| 0011A |
|
18 |
18 |
$748.00 |
| 90688 |
|
69 |
68 |
$683.20 |
| 0012A |
|
16 |
16 |
$664.00 |
| 0073A |
|
15 |
15 |
$600.00 |
| 0081A |
|
13 |
13 |
$552.00 |
| 0004A |
|
15 |
15 |
$536.00 |
| 0082A |
|
12 |
12 |
$496.00 |
| 92551 |
|
558 |
540 |
$445.60 |
| 85018 |
|
295 |
279 |
$338.98 |
| 96161 |
|
753 |
662 |
$333.81 |
| 83655 |
|
141 |
130 |
$325.00 |
| 96127 |
|
194 |
180 |
$284.30 |
| 90648 |
|
108 |
108 |
$253.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
47 |
43 |
$237.56 |
| 99188 |
|
41 |
39 |
$162.00 |
| 90716 |
|
15 |
15 |
$150.00 |
| 90671 |
|
13 |
13 |
$143.00 |
| 96160 |
|
189 |
173 |
$119.92 |
| 90670 |
|
96 |
96 |
$110.00 |
| 81002 |
|
48 |
44 |
$59.29 |
| 90656 |
|
55 |
55 |
$0.00 |
| 3008F |
|
788 |
711 |
$0.00 |
| 99000 |
|
404 |
329 |
$0.00 |
| 36416 |
|
93 |
90 |
$0.00 |
| 90660 |
|
31 |
31 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
88 |
86 |
$0.00 |
| 90677 |
|
14 |
12 |
$0.00 |
| 91300 |
|
612 |
522 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
181 |
170 |
$0.00 |
| 90685 |
|
30 |
30 |
$0.00 |